Literature DB >> 3986809

Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides.

S Odashima, T Ohta, H Kohno, T Matsuda, I Kitagawa, H Abe, S Arichi.   

Abstract

The effects of two plant glycosides, ginsenosides Rh1 and Rh2, on the growth and differentiation of mouse melanoma (B16) cells in culture were studied. These plant glycosides have a dammarane skeleton resembling a steroid skeleton as an aglycone. Ginsenoside Rh2 inhibits the growth of B16 melanoma cells, causes morphological alterations, and stimulates melanogenesis at high cellular density. When ginsenoside Rh2 was removed after 2 or 6 days of treatment, the growth rate recovered slightly but not completely, during the period of observation (4 days after removal). On the other hand, ginsenoside Rh1 does not inhibit the growth of melanoma cells even at concentrations over 100 microM but stimulates the expression of the melanotic phenotype. Ginsenosides Rh1 and Rh2, possessing a glucose molecule at C-6 and C-3, respectively, have very similar chemical structures, but their effects on B16 melanoma cells differ remarkably. While it appears that the degree of differentiation is inversely related to cell growth, the present observations suggest that the differentiation and growth capacity of this B16 melanoma subline are independent phenotypic expressions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986809

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Induction of apoptosis and reversal of permeability glycoprotein-mediated multidrug resistance of MCF-7/ADM by ginsenoside Rh2.

Authors:  Hui Zhang; Jian Gong; Huilai Zhang; Di Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  Ginseng--is there a use in clinical medicine?

Authors:  S K Chong; V G Oberholzer
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

3.  Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.

Authors:  Michung Yoon; Hyunghee Lee; Sunhyo Jeong; Jung-Jae Kim; Christopher J Nicol; Kung Woo Nam; Moonza Kim; Byung Goo Cho; Goo Taeg Oh
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng.

Authors:  Yoon Jae Kim; Jun Won Chung; So Jung Lee; Ki Seok Choi; Ju Hyun Kim; Ki Baik Hahm
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

5.  Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.

Authors:  Sunga Choi; Tae Woong Kim; Shivendra V Singh
Journal:  Pharm Res       Date:  2009-07-23       Impact factor: 4.200

6.  Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice.

Authors:  T Tode; Y Kikuchi; T Kita; J Hirata; E Imaizumi; I Nagata
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Isolation and characterization of a low metastatic variant from EL-4 mouse T-lymphoma.

Authors:  T Ota; M Tanino; H Kohno; H Funamoto; S Odashima
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

8.  Identification of Target Genes Involved in the Antiproliferative Effect of Enzyme-Modified Ginseng Extract in HepG2 Hepatocarcinoma Cell.

Authors:  Sung-Il Jang; Yeon-Weol Lee; Chong-Kwan Cho; Hwa-Seung Yoo; Jun-Hyeog Jang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

9.  The role of intestinal microflora in anti-inflammatory effect of baicalin in mice.

Authors:  Myung-Ah Jung; Se-Eun Jang; Sung-Woon Hong; Myung Joo Hana; Dong-Hyun Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

10.  Ginseng and Its Active Components Ginsenosides Inhibit Adipogenesis in 3T3-L1 Cells by Regulating MMP-2 and MMP-9.

Authors:  Jaeho Oh; Hyunghee Lee; Dongmin Park; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.